There is a binding domain within the PTEN promoter, which is a natural inhibitor of the PI3K/AKT pathway, and ROSI increases the expression of PTEN through activating PPAR-γ in HCC cell lines (92, 93). The gene discussed is PTEN; the disease is hepatocellular carcinoma.